Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2014-01-31
2019-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Assessment of Preoperative Versus Postoperative Submucosal Dexamethasone on Postoperative Complications Following Surgical Extraction of Mandibular Third Molar: Randomized Controlled Trial
NCT06160180
Effect of Dexamethasone and Methylprednisolone on Pain, Swelling and Trismus After Third Molar Surgery
NCT01603498
Perineural and Systemic Dexamethasone Use in Dental Surgeries in Terms of Anesthesia Duration and Postop Complaints
NCT06318013
Effect of Preemptive Etoricoxib and Dexamethasone on Wound Healing and Clinical Parameters After Third Molar Surgery
NCT05791721
Comparison of the Effects of Intraoral Postoperative Dexamethasone Applications After Mandibular Third Molar Surgery
NCT06604286
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intramuscular application
Intramuscular application of 4mg Dexamethasone
Intramuscular application
Patient receive 4mg of Dexamethasone by intramuscular application
Submucosal application
Submucosal application of 4mg Dexamethasone
Submucosal application
Patients receive 4mg of Dexamethasone by submucosal application
4mg Dexamethasone submucosal
4mg Dexamethasone submucosal application
4mg Dexamethasone submucosal
Patients receive 4mg of submucosal Dexamethasone
8mg Dexamethasone submucosal
8mg Dexamethasone submucosal application
8mg Dexamethasone submucosal
Patients receive 8mg of submucosal Dexamethasone
4mg Dexamethasone postoperative
4mg Dexamethasone postoperative application
4mg Dexamethasone preoperative
Patients receive 4mg of Dexamethasone preoperatively
4mg Dexamethasone preoperative
4mg Dexamethasone postoperative application
4mg Dexamethasone postoperative
Patients receive 4mg of Dexamethasone postoperatively
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intramuscular application
Patient receive 4mg of Dexamethasone by intramuscular application
Submucosal application
Patients receive 4mg of Dexamethasone by submucosal application
4mg Dexamethasone submucosal
Patients receive 4mg of submucosal Dexamethasone
8mg Dexamethasone submucosal
Patients receive 8mg of submucosal Dexamethasone
4mg Dexamethasone preoperative
Patients receive 4mg of Dexamethasone preoperatively
4mg Dexamethasone postoperative
Patients receive 4mg of Dexamethasone postoperatively
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Bilateral symmetrically impacted lower third molars according to Pel-Gregory's and Winter's classification
Exclusion Criteria
* Drug and / or alcohol abusers
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Belgrade
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Miroslav Andric
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miroslav M Andric, DDS, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Zagreb
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Dental Medicine
Belgrade, , Serbia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
36/11-2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.